Ragab Abdelhafiez Shokr <br/><br/>
Safety of statins in dyslipidemic patients with chronic hepatitis C viral infection /  
 دراسة درجة امان عقار الستاتين لدى مرضى الالتهاب الكبدى الفيروسى (سي) ذوى الكولسترول المرتفع 
Ragab Abdelhafiez Shokr ; Supervised Hesham Salah Eldin Taha , Sameh Wadae Bakhoum  
 - Cairo :   Ragab Abdelhafiez Shokr ,   2013 
 - 145 P. :   charts , facsimiles ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology 
<br/><br/> Some studies have shown that patients with hepatitis C are at increased risk cardiovascular disease based on increased carotid intima- media thickness⁴ . These increases in markers of early atherosclerosis in chronic hepatitis C may make 3- hydroxy -3- methylglutary 1 coenzyme A reductase inhibitors (statins) of a particular benefit in this patient population 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Dyslipidemic  Hepatitis C  Statins